Resignation of Non Executive Director Edward Rayner
Release Date: 14/08/2020 8:57am
Pharmaceutical research company Pharmaxis (ASX: PXS) today announced that its non-executive director Mr Edward Rayner has resigned from the Board effective 14 August 2020.
Mr Rayner joined the Pharmaxis Board in conjunction with a share placement to UK based Arix Bioscience plc in September 2018. At the time he was the investment director leading the Arix investment. Mr Rayner has recently commenced a new executive position with a UK life science technology company, having left Arix earlier this year.
Pharmaxis Chairman Malcolm McComas said, “We will miss Ed’s contribution as an experienced global specialist biotech investor, but we understand his need to focus on his new position and wish him well.”
Categories: News and Media